Abstract Details

Title A Responder Analysis of MPC-7869, a Selective Ab42-Lowering Agent, in Mild Alzheimer's Disease (AD): Analysis from a Phase 2 Study of up to 24 Months of Treatment.

Topic Aging and Dementia

Presentation(s) (-)

Poster/Presentation
Number 072

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Kenton Zavitz	No disclosure on file
Suzanne Hendrix, PhD (Pentara)	Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��